Akademska digitalna zbirka SLovenije - logo
E-resources
Full text
Peer reviewed
  • Inhibition of histone deace...
    Guo, Yu-Kun; Ming, Sheng-Li; Zeng, Lei; Chang, Wen-Ru; Pan, Jia-Jia; Zhang, Chao; Wan, Bo; Wang, Jiang; Su, Yu; Yang, Guo-Yu; Chu, Bei-Bei

    Molecular immunology, August 2021, 2021-08-00, 20210801, Volume: 136
    Journal Article

    •HDAC1 inhibition induces DNA damage response.•HDAC1 inhibition activates cGAS/STING/TBK1/IRF3 innate immune pathway.•HDAC1 inhibitor prevents PRV infection in vitro. Pseudorabies virus (PRV) is an enveloped double-stranded DNA virus that is the etiological agent of Aujeszky’s disease in pigs. Vaccination is currently available to prevent PRV infection, but there is still an urgent need for new strategies to control this infectious disease. Histone deacetylases (HDACs) are epigenetic regulators that regulate the histone tail, chromatin conformation, protein-DNA interaction and even transcription. Viral transcription and protein activities are intimately linked to regulation by histone acetyltransferases and HDACs that remodel chromatin and regulate gene expression. We reported here that genetic and pharmacological inhibition of HDAC1 significantly influenced PRV replication. Moreover, we demonstrated that inhibition of HDAC1 induced a DNA damage response and antiviral innate immunity. Mechanistically, the HDAC1 inhibition-induced DNA damage response resulted in the release of double-strand DNA into the cytosol to activate cyclic GMP-AMP synthase and the downstream STING/TBK1/IRF3 innate immune signaling pathway. Our results demonstrate that an HDAC1 inhibitor may be used as a new strategy to prevent Aujeszky’s disease in pigs.